OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The m6A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathway
Yi Zhang, Xiaomeng Liu, Yan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 65
Yi Zhang, Xiaomeng Liu, Yan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 65
Showing 1-25 of 65 citing articles:
Inhibition of ALKBH5 attenuates I/R-induced renal injury in male mice by promoting Ccl28 m6A modification and increasing Treg recruitment
Juntao Chen, Cuidi Xu, Kun Yang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 74
Juntao Chen, Cuidi Xu, Kun Yang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 74
Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review
Tohada M. AL‐Noshokaty, Abdallah Mansour, Rehab Abdelhamid, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154438-154438
Closed Access | Times Cited: 52
Tohada M. AL‐Noshokaty, Abdallah Mansour, Rehab Abdelhamid, et al.
Pathology - Research and Practice (2023) Vol. 245, pp. 154438-154438
Closed Access | Times Cited: 52
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Biological and pharmacological roles of m6A modifications in cancer drug resistance
Zaoqu Liu, Haijiao Zou, Qin Dang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 60
Zaoqu Liu, Haijiao Zou, Qin Dang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 60
Targeting lncRNA DDIT4‐AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy
Ting Jiang, Jiaojiao Zhu, Shilong Jiang, et al.
Advanced Science (2023) Vol. 10, Iss. 17
Open Access | Times Cited: 40
Ting Jiang, Jiaojiao Zhu, Shilong Jiang, et al.
Advanced Science (2023) Vol. 10, Iss. 17
Open Access | Times Cited: 40
RBM33 is a unique m6A RNA-binding protein that regulates ALKBH5 demethylase activity and substrate selectivity
Fang Yu, Allen Zhu, Shun Liu, et al.
Molecular Cell (2023) Vol. 83, Iss. 12, pp. 2003-2019.e6
Open Access | Times Cited: 31
Fang Yu, Allen Zhu, Shun Liu, et al.
Molecular Cell (2023) Vol. 83, Iss. 12, pp. 2003-2019.e6
Open Access | Times Cited: 31
RNA modification in cardiovascular disease: implications for therapeutic interventions
Cong Wang, Xuyang Hou, Qing Guan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 31
Cong Wang, Xuyang Hou, Qing Guan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 31
Natural antisense transcripts as versatile regulators of gene expression
Andreas Werner, Aditi Kanhere, Claes Wahlestedt, et al.
Nature Reviews Genetics (2024)
Closed Access | Times Cited: 13
Andreas Werner, Aditi Kanhere, Claes Wahlestedt, et al.
Nature Reviews Genetics (2024)
Closed Access | Times Cited: 13
Cancer‐associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF‐1α/miR‐21 axis under hypoxic conditions in pancreatic cancer
Keping Deng, Fang Zou, Jin Xu, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 3, pp. 524-537
Closed Access | Times Cited: 10
Keping Deng, Fang Zou, Jin Xu, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 3, pp. 524-537
Closed Access | Times Cited: 10
New mechanism of LncRNA: In addition to act as a ceRNA
Jiahao Zhang, Huike Zhu, Linjing Li, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1050-1060
Open Access | Times Cited: 10
Jiahao Zhang, Huike Zhu, Linjing Li, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1050-1060
Open Access | Times Cited: 10
Targeting Wnt Signaling in Cancer Drug Resistance: Insights from Pre-Clinical and Clinical Research
Kiavash Hushmandi, Mina Alimohammadi, Mohammad Heiat, et al.
Pathology - Research and Practice (2025) Vol. 267, pp. 155837-155837
Closed Access | Times Cited: 1
Kiavash Hushmandi, Mina Alimohammadi, Mohammad Heiat, et al.
Pathology - Research and Practice (2025) Vol. 267, pp. 155837-155837
Closed Access | Times Cited: 1
New insights into the interaction between m6A modification and lncRNA in cancer drug resistance
Yizhou Jin, Zhipeng Fan
Cell Proliferation (2023) Vol. 57, Iss. 4
Open Access | Times Cited: 18
Yizhou Jin, Zhipeng Fan
Cell Proliferation (2023) Vol. 57, Iss. 4
Open Access | Times Cited: 18
Mechanisms and clinical landscape of N6-methyladenosine (m6A) RNA modification in gastrointestinal tract cancers
Danhua Zhu, Kunkai Su, Xiaoxi Ouyang, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 7, pp. 1553-1570
Open Access | Times Cited: 8
Danhua Zhu, Kunkai Su, Xiaoxi Ouyang, et al.
Molecular and Cellular Biochemistry (2024) Vol. 479, Iss. 7, pp. 1553-1570
Open Access | Times Cited: 8
Novel insights into mutual regulation between N6-methyladenosine modification and LncRNAs in tumors
Nan Zhang, Yifei Sun, Zongqin Mei, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Nan Zhang, Yifei Sun, Zongqin Mei, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Insights into the m6A demethylases FTO and ALKBH5 : structural, biological function, and inhibitor development
Zewei Gao, Xuan Zha, Min Li, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Zewei Gao, Xuan Zha, Min Li, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Demethylases in tumors and the tumor microenvironment: Key modifiers of N6-methyladenosine methylation
Junchen Guo, Liang Zhao, Meiqi Duan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116479-116479
Open Access | Times Cited: 5
Junchen Guo, Liang Zhao, Meiqi Duan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116479-116479
Open Access | Times Cited: 5
Long Noncoding RNAs and Cancer Stem Cells: Dangerous Liaisons Managing Cancer
Silvia Anna Ciafrè, Monia Russo, Alessandro Michienzi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1828-1828
Open Access | Times Cited: 10
Silvia Anna Ciafrè, Monia Russo, Alessandro Michienzi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1828-1828
Open Access | Times Cited: 10
Role of Autophagy Mediated by AMPK/DDiT4/mTOR Axis in HT22 Cells Under Oxygen and Glucose Deprivation/Reoxygenation
Yi Zhang, Luyao Liu, Xianming Hou, et al.
ACS Omega (2023) Vol. 8, Iss. 10, pp. 9221-9229
Open Access | Times Cited: 10
Yi Zhang, Luyao Liu, Xianming Hou, et al.
ACS Omega (2023) Vol. 8, Iss. 10, pp. 9221-9229
Open Access | Times Cited: 10
METTL14 Facilitates the Metastasis of Pancreatic Carcinoma by Stabilizing LINC00941 in an m6A-IGF2BP2-Dependent Manner
Jiawei Lu, Lanting Yu, Ni Xie, et al.
Journal of Cancer (2023) Vol. 14, Iss. 7, pp. 1117-1131
Open Access | Times Cited: 10
Jiawei Lu, Lanting Yu, Ni Xie, et al.
Journal of Cancer (2023) Vol. 14, Iss. 7, pp. 1117-1131
Open Access | Times Cited: 10
The Mechanism and Latest Progress of m6A Methylation in the Progression of Pancreatic Cancer
Zehao Liu, Peng Ma, Ying He, et al.
International Journal of Biological Sciences (2025) Vol. 21, Iss. 3, pp. 1187-1201
Open Access
Zehao Liu, Peng Ma, Ying He, et al.
International Journal of Biological Sciences (2025) Vol. 21, Iss. 3, pp. 1187-1201
Open Access
Heterogenic membrane-coated nanoparticles for targeted immunotherapy against osteosarcoma via p53-mediated ferroptosis and mTOR inhibition
Ting Lei, Zichao Jiang, Jing Nan, et al.
Chemical Engineering Journal (2025), pp. 160854-160854
Closed Access
Ting Lei, Zichao Jiang, Jing Nan, et al.
Chemical Engineering Journal (2025), pp. 160854-160854
Closed Access
SIRT3 Regulates H3K9Ac Modification to Affect DDIT4 Involved in Abnormal Hepatic Lipid Metabolism in Male Offspring of Paternal High‐Fat Diet
Yan Zhao, Dan Zhu, Yajun Shi, et al.
Journal of Food Biochemistry (2025) Vol. 2025, Iss. 1
Open Access
Yan Zhao, Dan Zhu, Yajun Shi, et al.
Journal of Food Biochemistry (2025) Vol. 2025, Iss. 1
Open Access
The role of LncRNA-MANCR induced by HIF-1α drive the malignant progression of pancreatic cancer by targeting miRNA-494/SIRT1 signaling axis under hypoxic conditions
Yan Jin, Hao Hu, Yitong Tian, et al.
Cancer Gene Therapy (2025)
Open Access
Yan Jin, Hao Hu, Yitong Tian, et al.
Cancer Gene Therapy (2025)
Open Access
Role of noncoding RNA and protein interaction in pancreatic cancer
Zhang Li, Tingting Zhang, Yang Xiao-juan, et al.
Chinese Medical Journal (2025)
Open Access
Zhang Li, Tingting Zhang, Yang Xiao-juan, et al.
Chinese Medical Journal (2025)
Open Access
Summary of the mechanism of ferroptosis regulated by m6A modification in cancer progression
Bin Fan, Gangxian Chen, Shu‐Yi Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Bin Fan, Gangxian Chen, Shu‐Yi Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
